Johnson & Johnson Stock Performance Analysis
Analysis based on 8 articles · First reported Jul 02, 2025 · Last updated Sep 01, 2026
The articles provide a routine analysis of Johnson & Johnson's stock performance and valuation, which may influence investor perception but is unlikely to cause significant market movements. The downward estimate revisions and Hold rating suggest a neutral to slightly negative short-term outlook for JNJ shares.
Multiple articles from Zacks Investment Research analyze the recent stock performance of Johnson & Johnson (JNJ), comparing its daily and monthly returns against major indices such as the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite. The articles highlight JNJ's upcoming earnings release, with consensus estimates for EPS and revenue, and discuss valuation metrics like Forward P/E and PEG ratios. They also note recent downward revisions to analyst estimates and assign JNJ a Zacks Rank of #3 (Hold). The coverage spans different dates, showing varied stock movements and sector comparisons, but consistently focuses on JNJ's relative performance and financial outlook.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard